Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000218 · ClinicalTrials.gov registry record · Phase 4
Pharmacotherapy and Intensive Treatment - 2
A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 4
- Development phase
- 353
- Enrollment target
NCT00000218 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 353 participants.
The verdict
NCT00000218, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 353 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Interventions
- DRUG Carbamazepine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Est. Completion | 2005-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000218
The ClinicalTrials.gov registry entry for NCT00000218 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 353 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carbamazepine is the first listed.
NCT00000218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000218 about?
NCT00000218 is a clinical study titled "Pharmacotherapy and Intensive Treatment - 2". The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
What is the current status of trial NCT00000218?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 353 participants. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00000218?
The interventions under investigation include: Carbamazepine (DRUG).
Who is sponsoring clinical trial NCT00000218?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.